HARARE, May 14 (NewsDay Live) – Zimbabwe’s latest healthcare fee reductions may ease pressure on private medical operators, but there is little evidence patients will see lower consultation charges or cheaper medicines any time soon.
On Tuesday this week, Finance Minister Mthuli Ncube announced a package of regulatory reforms that included abolishing Health Professions Authority (HPA) licence fees for wholesalers and cutting practitioner registration fees by 20% to 30%.
The measures were presented as part of broader efforts to improve the business environment and reduce operating costs across sectors.
But in healthcare, lower regulatory fees do not automatically translate into lower prices for patients, according to critics.
The main reason is structural: Zimbabwe has no binding mechanism requiring private hospitals, pharmacies or doctors to pass cost savings on to consumers.
Private consultation fees are largely determined by individual providers and market conditions. Industry tariff schedules published by medical associations act more as guidelines than enforceable price controls.
As a result, reduced licensing costs are more likely to be absorbed as operating relief by healthcare providers still grappling with inflation, currency volatility, fuel costs and expensive imported medical supplies.
“Lowering the cost of a licence is one thing, but clinics are still running generators on diesel and importing medicines at high cost,” said a representative of a local medical advocacy group.
- Budget dampens workers’ hopes
- Govt issues $24 billion Covid-19 guarantees
- Letter to my People:They have no answers for Nero’s charisma
- ZMX to enhance farm profitability
Keep Reading
“A 20% cut in an annual licence fee does not materially change the daily cost of care.”
The government’s reforms also leave intact one of the biggest sources of public frustration in private healthcare: medical aid shortfalls.
Zimbabwe’s healthcare financing system often leaves patients paying significant out-of-pocket balances when insurers reimburse less than the amount charged by doctors or hospitals.
That gap persists despite recent regulatory changes.
The Insurance and Pensions Commission Amendment Act of 2024, enacted in April 2026, brought Medical Aid Societies under the direct supervision of the Insurance and Pensions Commission (IPEC). The reforms strengthened oversight of insurers’ financial health and governance.
But IPEC still does not directly regulate what private practitioners charge patients.
If a doctor charges US$50 for a consultation and a medical aid scheme reimburses US$20, the patient remains responsible for the US$30 difference. The new fee reductions do not address that imbalance.
The recently launched Consumer Protection Policy (2026-2030) also offers limited immediate relief for healthcare consumers.
While the policy targets unfair pricing practices broadly, healthcare remains a regulatory grey area. The HPA oversees professional standards and ethics, not pricing.
That leaves policymakers confronting a deeper question: whether healthcare should continue operating primarily as a market-priced service in an economy where incomes have failed to keep pace with medical inflation.
For now, the latest reforms appear aimed more at stabilising healthcare businesses than lowering household medical costs.
Unless authorities introduce mechanisms linking regulatory relief to price reductions or tighter controls on medical billing, patients are unlikely to feel the impact of the cuts at the clinic counter or pharmacy till.
For most Zimbabweans, the cost of care remains largely unchanged.
